|
業務類別
|
Biotechnology |
|
業務概覽
|
Immatics NV is a clinical-stage biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies. The company derives its maximum revenue from United States. |
| 公司地址
| Paul-Ehrlich-Strasse 15, Tubingen, BW, DEU, 72076 |
| 電話號碼
| +49 707153970 |
| 傳真號碼
| +49 70715397900 |
| 公司網頁
| https://www.immatics.com |
| 員工數量
| 711 |
| Dr. Carsten Reinhardt,M.D.,PhD |
Chief Development Officer |
-- |
05/03/2026 |
| Mr. Jordan Silverstein |
Head of Strategy |
-- |
05/03/2026 |
| Dr. Harpreet Singh, PhD |
Director and Chief Executive Officer |
歐元 533.00K |
05/03/2026 |
| Dr. Cedrik Britten, M.D. |
Chief Medical Officer |
-- |
05/03/2026 |
| Dr. Toni Weinschenk, PhD |
Chief Innovation Officer |
-- |
05/03/2026 |
| Dr. Rainer Kramer, PhD |
Chief Business Officer |
-- |
05/03/2026 |
| Dr. Steffen Walter, PhD |
Chief Operations Officer |
-- |
05/03/2026 |
| Dr. Venkat Ramanan, PhD |
Chief Financial Officer |
-- |
05/03/2026 |
| Mr. Edward Sturchio, J.D. |
General Counsel |
-- |
05/03/2026 |
| Ms. Amie Krause |
Chief People Officer |
-- |
05/03/2026 |
|
|
| Ms. Heather L. Mason |
Independent Director |
05/03/2026 |
| Mr. Michael G. Atieh |
Independent Director |
05/03/2026 |
| Mr. Paul Rutherford Carter |
Independent Director |
05/03/2026 |
| Mr. Peter Alan Chambre |
Chairman of the Board |
05/03/2026 |
| Dr. Alise S. Reicin, M.D. |
Director |
05/03/2026 |
| Dr. Mathias Hothum, PhD |
Director |
05/03/2026 |
| Mr. Adam Stone |
Director |
05/03/2026 |
| Dr. Eliot Richard Forster, M.B.A.,PhD |
Independent Director |
05/03/2026 |
| Dr. Harpreet Singh, PhD |
Director and Chief Executive Officer |
05/03/2026 |
|
|
|
|
